← Back to Screener
iRhythm Holdings, Inc. Common Stock (IRTC)
Price$109.17
Value ScoreD
Growth ScoreA
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-48.81%
Price vs S&P 500 (4W)-10.68%
VGM Score45.43
Market Capitalization$3.74B
All Metrics
P/CF (Annual)46.29x
Book Value / Share (Quarterly)$4.91
P/TBV (Annual)11.13x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)22.05%
Cash Flow / Share (Quarterly)$0.57
Price vs S&P 500 (YTD)-46.74%
Gross Margin (TTM)71.00%
Net Profit Margin (TTM)-3.53%
EPS (TTM)$-0.86
10-Day Avg Trading Volume0.54M
EPS Excl Extra (TTM)$-0.86
Revenue Growth (5Y)23.02%
EPS (Annual)$-1.39
ROI (Annual)-5.55%
Gross Margin (Annual)70.57%
Net Profit Margin (5Y Avg)-21.97%
Cash / Share (Quarterly)$16.73
Revenue Growth QoQ (YoY)25.66%
ROA (Last FY)-4.37%
Revenue Growth TTM (YoY)27.36%
EBITD / Share (TTM)$-0.63
ROE (5Y Avg)-59.45%
Operating Margin (TTM)-5.21%
Cash Flow / Share (Annual)$1.07
P/B Ratio23.22x
P/B Ratio (Quarterly)24.05x
Net Income / Employee (Annual)$-18,600
EV / Revenue (TTM)5.27x
Net Interest Coverage (TTM)-32.60x
ROA (TTM)-2.79%
EPS Incl Extra (Annual)$-1.39
Current Ratio (Annual)4.63x
Quick Ratio (Quarterly)4.79x
3-Month Avg Trading Volume0.59M
52-Week Price Return-19.92%
EV / Free Cash Flow (Annual)120.31x
Revenue / Employee (TTM)$328,300
Tangible BV / Share (Quarterly)$7.15
P/S Ratio (Annual)5.01x
Asset Turnover (Annual)0.73x
52-Week High$212.00
Operating Margin (5Y Avg)-22.51%
EPS Excl Extra (Annual)$-1.39
CapEx CAGR (5Y)27.88%
Tangible BV CAGR (5Y)24.88%
26-Week Price Return-32.88%
Quick Ratio (Annual)4.34x
13-Week Price Return-18.75%
Total Debt / Equity (Annual)4.25x
Current Ratio (Quarterly)5.17x
Enterprise Value$4.15B
Revenue / Share Growth (5Y)19.60%
Asset Turnover (TTM)0.79x
Book Value / Share Growth (5Y)-16.68%
Revenue / Employee (Annual)$311,300
Inventory Turnover (Annual)12.33x
Pretax Margin (Annual)-5.84%
Cash / Share (Annual)$18.07
3-Month Return Std Dev42.58%
Gross Margin (5Y Avg)68.30%
Net Income / Employee (TTM)$-11,600
ROE (Last FY)-29.17%
Net Interest Coverage (Annual)-15.34x
EPS Basic Excl Extra (Annual)$-1.39
P/FCF (TTM)72.22x
Receivables Turnover (TTM)9.76x
EV / Free Cash Flow (TTM)221.47x
Total Debt / Equity (Quarterly)4.03x
EPS Incl Extra (TTM)$-0.86
Receivables Turnover (Annual)9.60x
ROI (TTM)-3.54%
P/S Ratio (TTM)4.75x
Pretax Margin (5Y Avg)-21.86%
Revenue / Share (Annual)$23.35
Tangible BV / Share (Annual)$7.91
Forward P/E228.59x
Price vs S&P 500 (52W)-48.13%
Year-to-Date Return-35.81%
5-Day Price Return-2.28%
EPS Normalized (Annual)$-1.39
ROA (5Y Avg)-18.57%
Net Profit Margin (Annual)-5.96%
Month-to-Date Return-11.81%
Cash Flow / Share (TTM)$-2.96
EBITD / Share (Annual)$-1.15
Operating Margin (Annual)-7.68%
LT Debt / Equity (Annual)4.25x
P/CF (TTM)59.81x
ROI (5Y Avg)-29.45%
LT Debt / Equity (Quarterly)4.03x
EPS Basic Excl Extra (TTM)$-0.86
P/TBV (Quarterly)12.15x
P/B Ratio (Annual)37.43x
Inventory Turnover (TTM)11.98x
Pretax Margin (TTM)-3.43%
Book Value / Share (Annual)$4.73
Price vs S&P 500 (13W)-28.49%
Beta1.28x
P/FCF (Annual)108.43x
Revenue / Share (TTM)$24.24
ROE (TTM)-20.60%
52-Week Low$108.81
vGradeD
gGradeA
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.35est. -0.66
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.27
4.32
4.33
4.33
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IRTCiRhythm Holdings, Inc. Common Stock | D | A | D | $109.17 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
iRhythm Holdings develops and commercializes the Zio System, an FDA-cleared digital platform for ambulatory cardiac monitoring that combines a wire-free, wearable biosensor with proprietary cloud-based analytics software. The system enables clinicians to diagnose arrhythmias more quickly and efficiently than traditional monitoring methods by continuously recording electrocardiogram data over 14 days. Designed for improved diagnostic accuracy and clinical efficiency, Zio addresses a key need in cardiac care monitoring.